Jul 27, 2026 08:01AM
Jul 27, 2026 08:00AM
Jul 14, 2026 08:04AM
Jul 14, 2026 08:00AM
Jun 15, 2026 08:00AM
Jun 15, 2026 08:00AM
Jun 10, 2026 09:08PM Humacyte prices $50 million stock offering at $1.05 per share
Jun 10, 2026 09:08PM
Jun 10, 2026 08:56PM
Jun 10, 2026 08:55PM
Jun 10, 2026 08:55PM
Jun 10, 2026 04:04PM
Jun 10, 2026 04:04PM
Jun 10, 2026 04:01PM Humacyte ATEV shows superior results in dialysis access trial
Jun 10, 2026 04:01PM
Jun 1, 2026 09:02AM
May 26, 2026 08:03AM
May 26, 2026 08:00AM
May 20, 2026 08:03AM
May 20, 2026 08:00AM
May 13, 2026 07:00AM Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026 08:01AM
May 12, 2026 08:00AM
May 8, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 24, 2026 08:01AM
Apr 24, 2026 08:00AM
Apr 22, 2026 08:01AM Humacyte names Jim Mercadante as chief commercial officer
Apr 22, 2026 08:00AM
Apr 21, 2026 08:01AM
Apr 21, 2026 08:00AM
Mar 27, 2026 07:00AM
Mar 26, 2026 08:00AM
Mar 26, 2026 08:00AM
Mar 23, 2026 08:00AM Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
Mar 23, 2026 08:00AM
Mar 19, 2026 08:33AM
Mar 19, 2026 08:31AM
Mar 19, 2026 08:30AM
Mar 19, 2026 08:30AM
Mar 17, 2026 08:57AM
Mar 17, 2026 08:01AM Humacyte submits application for Symvess approval in Israel
Mar 17, 2026 08:00AM
Mar 2, 2026 08:00AM
Feb 18, 2026 08:00AM
Feb 9, 2026 01:43PM
Feb 9, 2026 08:01AM
Feb 9, 2026 08:00AM
Jan 8, 2026 08:00AM Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
Jan 5, 2026 08:01AM

326,541 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All